[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
August 1, 2001

New Oral Contraceptive

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;286(5):527. doi:10.1001/jama.286.5.527

The FDA has approved drospirenone, 3.0 mg, and ethinyl estradiol, 0.030 mg (Yasmin 28 tablets; Berlex Laboratories, Wayne, NJ), an oral contraceptive, for prevention of pregnancy. The drug was approved on the basis of results of clinical studies of up to 2 years' duration, in which 2629 women completed 33 160 cycles of Yasmin use without any other contraception. Their mean (SD) age was 25.5 (4.7) years, and the pregnancy rates in these studies were less than 1 per 100 person-years of use.

First Page Preview View Large
First page PDF preview
First page PDF preview
×